Improvement in CD 4 counts in HIV positive patients treated with HAART and antitubercular drugs: An observational study from North India

Indian Journal of Pathology and Microbiology

Volumn 50, Issue 4, 2007, Pages 905-907

  Sharma, Aman ^a   Wanchu, Ajay ^a   Bansal, Vishal ^a   Singh, Surjit ^a   Varma, Subhash ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antitubercular drugs; CD4 counts; HAART; HIV; North India

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE MARKER; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INDIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; INDIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TUBERCULOSIS;

EID: 37349067100     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention and treatment. Lancet2006; 368: 489-504.
2. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med1999; 340:367-73.
3. Silversides A. HIV/TB coinfection rising. CMAJ2006; 175: 725-6
4. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of Human Immuno-deficiency Virus Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy. Clin Infect Dis2000; 30:S5-14.
5. Elliott AM, Luzze H and Quigley MA et al. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J Infect Dis2004; 190:869-78.
6. http://dsacs.delhigovt.nic.in/naco_pdf/guideline_11.pdf accessed on 20-02-2007.
7. http://whqlibdoc.who.int/hq/2007WHO_HTM_TB_2007.379_eng.pdf accessed on 20-02-2007.
8. Pathni AK, Chauhan LS. HIV/ TB in India:a public health challenge. JIMA2003; 101:148-9.
9. + lymphocyte counts < 350 cells/microliter. CID2003; 37:951-8.
10. CR Horsburgh Jr, Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;20:2060-7.
11. Corbett EL, Watt CJ,Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med2003; 163:1009-21.
12. Burman WJ, Jones BE. Clinical and radiographic features of HIV-related tuberculosis. Semin Respir Infect2003; 18:263-71.
13. Vajpayee M, Kanswal S, Seth P, Wig N, Pandey RM. Tuberculosis infection in HIV infected Indian patients. AIDS patient care. STD2004; 18:209-13.
14. The strategies for the management of antiretroviral therapy (SMART) study group. CD4+ count guided interruption of antiretroviral treatment. N Engl J Med2006; 355:2283-96.